欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2523/001
药品名称
Niviron
活性成分
Ascorbic acid 500.0 mg
Glucose 1000.0 mg
Nicotinamide 160.0 mg
PYRIDOXINE HYDROCHLORIDE 50.0 mg
Riboflavin 4.0 mg
Thiamine hydrochloride 250.0 mg
剂型
Concentrate for solution for infusion
上市许可持有人
Macure Healthcare Limited, Malta
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Denmark (DK)
Niviron
Norway (NO)
Finland (FI)
许可日期
2025/04/16
最近更新日期
2025/08/22
药物ATC编码
A11EB Vitamin B-complex with vitamin C
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Hybrid application (Art 10.3 Dir 2001/83/EC)
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
Fina SPC
Final PL
|
Final PL
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase